EGR3 and leukemia: Surprisingly, re-analysis of the Leukemia MILE study data involving 2096 patient samples using the online database BloodSpot revealed B cell malignancies to be characterized by a decreased EGR3 gene expression in comparison to healthy bone marrow (BM) (Supplementary Fig. 1A) [26, 27].